Work

PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline

Year: 2020

Type: article

Source: Obstetrical & Gynecological Survey

DOI: 10.1097/ogx.0000000000000869

Authors: William P. Tew, Christina Lacchetti, Annie Ellis, Kathleen Maxian, Susana Banerjee, Michael Bookman, Monica Brown Jones, Jung-Min Lee, Stéphanie Lheureux, Joyce F. Liu, Kathleen N. Moore, Carolyn Muller, Patricia Rodriguez, Christine Walsh, Shannon N. Westin, Elise C. Kohn

Institutions: American Society of Clinical Oncology, Royal Marsden NHS Foundation Trust, University Health Network, Memorial Sloan Kettering Cancer Center, Kaiser Permanente, University of New Mexico, Anne Arundel Medical Center, Dana-Farber Cancer Institute, National Cancer Institute

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3111845820

FWCI: 1.376

Cites:

Cited by: 18

Related to: 10